Interleukin-18 is a proinflammatory biomarker produced by macrophages and is increased in other types of hypersensitivity reactions in people (53, 54), therefore it was included in this study for its potential as a discriminatory biomarker. Here, IL18 is linked to hypersensitivity reaction disease.